Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with
Algeria
Bordetella pertussis
Kendrick test
LD50
relative potency
whole-cell pertussis vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
06 Jun 2022
06 Jun 2022
Historique:
received:
16
03
2022
revised:
12
05
2022
accepted:
18
05
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
In Algeria, vaccination against pertussis is carried out using the whole-cell pertussis vaccine combined with the diphtheria and tetanus toxoids (DTwp). The quality control of vaccines locally produced or imported is carried out before the batch release. The aim of our work was to evaluate the potency of pertussis vaccines. In the present study, five consecutive trials of potency were conducted on samples of the same batch of (DTwp) using the mouse protection test (MPT) against experimental infection of
Identifiants
pubmed: 35746514
pii: vaccines10060906
doi: 10.3390/vaccines10060906
pmc: PMC9230502
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Curr Opin Immunol. 2019 Aug;59:72-78
pubmed: 31078081
Braz J Infect Dis. 2013 May-Jun;17(3):385-6
pubmed: 23607918
J Hyg (Lond). 1960 Mar;58:57-93
pubmed: 14413273
J Pathol Bacteriol. 1966 Jan;91(1):173-9
pubmed: 5941389
Infect Immun. 1984 Jan;43(1):263-9
pubmed: 6317569
Braz J Microbiol. 2012 Apr;43(2):429-31
pubmed: 24031848
Vaccine. 2021 May 27;39(23):3120-3130
pubmed: 33934917
J Infect Dev Ctries. 2016 Nov 24;10(11):1191-1199
pubmed: 27886031
J Gen Microbiol. 1970 Oct;63(2):211-20
pubmed: 4324651
PLoS Pathog. 2020 Jul 23;16(7):e1008625
pubmed: 32702023
World Health Organ Tech Rep Ser. 2015;(993):1-262
pubmed: 26714369
J Biol Stand. 1981 Oct;9(4):351-65
pubmed: 7320018
J Immunoassay. 1987;8(4):309-18
pubmed: 3680532
Expert Rev Vaccines. 2014 Oct;13(10):1175-82
pubmed: 25182836
Bioanalysis. 2018 Feb;10(3):163-180
pubmed: 29333863
Vaccine. 2018 Aug 28;36(36):5460-5469
pubmed: 29180031
Jpn J Microbiol. 1965 Mar;9(1):21-33
pubmed: 5294323
Vaccine. 2001 Nov 12;20(3-4):342-51
pubmed: 11672896
Vaccines (Basel). 2020 May 13;8(2):
pubmed: 32414005
Dev Biol Stand. 1996;86:271-81
pubmed: 8785956
Expert Rev Vaccines. 2014 Oct;13(10):1265-70
pubmed: 25029905
Vaccine. 1998 Jan;16(1):16-23
pubmed: 9607004
J Bacteriol. 1989 Nov;171(11):6206-12
pubmed: 2478524
Dev Biol Stand. 1999;101:95-103
pubmed: 10566781
Biologicals. 2010 Nov;38(6):644-51
pubmed: 20709568
Am J Public Health Nations Health. 1947 Jul;37(7):803-10
pubmed: 18016555
Pharmeuropa Bio. 2008 Dec;2008(1):7-18
pubmed: 19220977
Arch Razi Inst. 2019 Jun;74(2):103-109
pubmed: 31232559
Expert Rev Vaccines. 2014 Oct;13(10):1163-5
pubmed: 25020131
Biologicals. 1991 Apr;19(2):107-11
pubmed: 1888489
Vaccine. 2020 Jan 29;38(5):1271-1276
pubmed: 31780181
Adv Appl Microbiol. 1976;20:57-80
pubmed: 187021
Biologicals. 1996 Dec;24(4):363-70
pubmed: 9088553
Heliyon. 2018 Jun 26;4(6):e00664
pubmed: 29998194
Clin Microbiol Rev. 2016 Jul;29(3):449-86
pubmed: 27029594
Adv Exp Med Biol. 2019;1183:127-136
pubmed: 31321754
Immunology. 1958 Apr;1(2):123-34
pubmed: 13538529
Vaccine. 2009 Nov 16;27(49):6824-32
pubmed: 19765397